Quality Control News and Research

RSS

China's SFDA finds certain batches of Jiangsu Yanshen's human use rabies vaccine substandard

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") issued a statement on its investigation into the human use rabies vaccine manufactured by Jiangsu Yanshen Biological Technology Stock Co., Ltd.. Simcere obtained a controlling stake in Jiangsu Yanshen on October 24, 2009.

5 Apr 2010

Beike Biotechnology awarded ISO9001 certification for implementation of comprehensive QMS

Beike Biotechnology Co. Ltd., one of the world's leading biotechnology companies focusing on adult stem cell therapies, has been awarded ISO9001 certification by the International Organization for Standardization ("ISO"). This internationally recognized designation signifies Beike has established a Quality Management System (QMS) that complies with ISO9001 standards.

3 Apr 2010

Petition to impose anti dumping duties on glyphosate imports from China: Aceto comments

Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today issued the following comment regarding the petition brought before the U.S. Department of Commerce and U.S. International Trade Commission to impose anti dumping duties on imports of glyphosate from China.

3 Apr 2010

Mislabeled high fire risk kids nightwear recalled by Big W

Big W stores in Australia have apologized after selling inflammable children’s night wear labeled as “low fire danger”. Australian Competition and Consumer Commission (ACCC) deputy chair Peter Kell said in a statement, "The ACCC enforces a mandatory standard for the labelling of children's nightwear,” "It is designed to reduce the risk of burns injuries to children by providing specific information on the fire hazard," he said. "There is considerable research which shows that clear labelling helps minimise the risk of these injuries, which is why the ACCC regularly monitors compliance."

1 Apr 2010

Tanda Professional Restore light therapy now made available for at-home use

During a press conference yesterday, doctors and experts unveiled a groundbreaking medical device using the healing properties of light therapy for pain management and improving mobility. For the first time ever, a licensed medical device that delivers clinical levels of light therapy only previously available in a doctor's office, has now been made available for at-home use.

1 Apr 2010

Roche Diagnostics' CoaguChek XS Plus system granted CLIA-waived status

Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the CoaguChek® XS Plus system, a point-of-care anticoagulation monitor that offers connectivity and data management tools to help healthcare professionals manage PT/INR (blood clotting time) testing.

From Roche Sequencing and Life Science 31 Mar 2010

Dr Patel ignored advice from colleagues

The charges of manslaughter that Dr Patel has been facing over three patients he had operated on between 2003 and 2005 are now on trial in the Supreme Court in Brisbane. The patients were Mervyn John Morris, 75 , Ames Edward Phillips, 46, and Geradus Wihelmus Gosewinus Kemps, 77. Dr Patel is also charged with one grievous bodily harm case besides these three manslaughter charges to Ian Rodney Vowles, 62.

30 Mar 2010

3 jurors out of Patel manslaughter case in the first 6 days of trial

Another Juror in the manslaughter trail of Dr. Jayant Patel has been discharged from her duties in a latest development. She is the third in the last six days of the trial at the Supreme Court in Brisbane

29 Mar 2010

NZ Doctor struck off for misconduct

While all names have been suppressed to protect the identities of those involved, the case has caught the imagination of the media. “Dr N” who admitted to professional misconduct before the Health Practitioners Disciplinary Tribunal was reported to have appealed to the High Court against being struck off by The Weekend Herald on Saturday. The appeal was unsuccessful.

29 Mar 2010

New edition of Cardiac Intensive Care to be published

A new edition of Cardiac Intensive Care, the only textbook dedicated to cardiac intensive care medicine, chronicles the progress made in the diagnosis and treatment of patients with critical cardiac illness during an era in which clinical cardiology has become a progressive and interventional field.

27 Mar 2010

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment

26 Mar 2010

FDA to take enforcement action regarding Genzyme's Allston plant

Genzyme Corporation announced today that the FDA notified the company yesterday afternoon that, while the agency recognizes Genzyme’s efforts, it intends to take enforcement action to ensure that products manufactured at the plant are made in compliance with good manufacturing practice regulations. The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant’s operation for an extended period and certify compliance with FDA regulations.

26 Mar 2010

Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors (SSRIs), prescribed drugs that inhibit the effect of an important enzyme. Now researchers have developed a strategy for overcoming this problem, the seventh European Breast Cancer Conference (EBCC7) in Barcelona will hear today (Wednesday).

25 Mar 2010

Outcomes Health Information Solutions moves into new headquarters in Alpharetta, GA

Outcomes Health Information Solutions, LLC, a leading healthcare data auditing and analytics company, announced today its move into its new headquarters in Alpharetta, GA. Now occupying nearly 47,000 square feet, the expansion confirms the company’s sustained rapid growth in the healthcare market.

22 Mar 2010

SBRT can improve survival rates for patients with inoperable non-small cell lung cancer

Highly-focused stereotactic body radiation therapy (SBRT) can eliminate the targeted tumor while avoiding treatment-related illness and may ultimately improve survival for patients with inoperable non-small cell lung cancer, according to early findings of a Radiation Therapy Oncology Group study published in the March 17 cancer-themed issue of the Journal of the American Medical Association.

18 Mar 2010

SBRT improves survival in patients with inoperable non-small cell lung cancer

17 Mar 2010

Angioplasty: Complexity of heart disease, gender and body size influence cumulative radiation skin dose

Body size, gender and the complexity of heart disease significantly influence how much cumulative radiation skin dose that patients receive during percutaneous coronary intervention (PCI) therapy, also known as angioplasty, according to a new Mayo Clinic study. The study was undertaken as a quality control initiative to reduce the potential radiation risks of cancer to patients and PCI operators.

16 Mar 2010

TeamHealth acquires emergency physician group RIEP

TeamHealth announced today the acquisition of Rhode Island Emergency Physicians (RIEP), the emergency physician group that staffs the emergency department at South County Hospital in Wakefield, Rhode Island. South County Hospital chose TeamHealth, who will work with the existing group of physicians to provide management and staffing services for the hospital's 30,000 annual patient volume emergency department.

16 Mar 2010

Aceto's future global headquarters: Building purchased in Port Washington, New York

Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has purchased a building in Port Washington, New York to be the site of its future global headquarters.

16 Mar 2010

Neoprobe meets with FDA to review Phase 3 clinical trial results of Lymphoseek drug

Neoprobe Corporation, a diversified developer of innovative oncology and surgical diagnostic and treatment products, today announced that it recently met with the United States Food and Drug Administration to review the clinical trial results of a Phase 3 investigational new drug, Lymphoseek®.

12 Mar 2010

Quality Control News and Research

China's SFDA finds certain batches of Jiangsu Yanshen's human use rabies vaccine substandard

Beike Biotechnology awarded ISO9001 certification for implementation of comprehensive QMS

Petition to impose anti dumping duties on glyphosate imports from China: Aceto comments

Mislabeled high fire risk kids nightwear recalled by Big W

Tanda Professional Restore light therapy now made available for at-home use

Roche Diagnostics' CoaguChek XS Plus system granted CLIA-waived status

Dr Patel ignored advice from colleagues

3 jurors out of Patel manslaughter case in the first 6 days of trial

NZ Doctor struck off for misconduct

New edition of Cardiac Intensive Care to be published

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment

FDA to take enforcement action regarding Genzyme's Allston plant

Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

Outcomes Health Information Solutions moves into new headquarters in Alpharetta, GA

SBRT can improve survival rates for patients with inoperable non-small cell lung cancer

SBRT improves survival in patients with inoperable non-small cell lung cancer

Angioplasty: Complexity of heart disease, gender and body size influence cumulative radiation skin dose

TeamHealth acquires emergency physician group RIEP

Aceto's future global headquarters: Building purchased in Port Washington, New York

Neoprobe meets with FDA to review Phase 3 clinical trial results of Lymphoseek drug

eBook: Comprehensive quality control solutions for biologics manufacturing eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News